Vaxcyte PCVX
NASDAQ PCVX
$56.05 -0.85 (-1.49%)
At close: Oct 1, 2026 · 4:00 PM EDT

Vaxcyte (PCVX) Selling, General & Administrative (2019 - 2026)

Updated

Vaxcyte (PCVX) recorded Selling, General & Administrative of $34.93 million in Q2 2026, up 9.0% from $32.04 million a year earlier and up 5.6% from the prior quarter.

Analysis

Vaxcyte (PCVX) Selling, General & Administrative (2019 - 2026) Analysis & Trends

On a TTM basis, Vaxcyte's Selling, General & Administrative came in at $132.67 million as of Jun 30, 2026, up 14.1% year-over-year; for FY2025, it came in at $129.37 million, up 39.3% from FY2024.

  • Annual Selling, General & Administrative has increased for seven straight years, with a five-year compound annual growth rate of 51.9% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $92.9 million in FY2024 (+53.1%), $60.7 million in FY2023 (+52.5%), $39.81 million in FY2022 (+57.6%) and $25.26 million in FY2021 (+57.7%).
  • The Q2 2026 figure is the highest quarterly Selling, General & Administrative in data going back to Q1 2019.
  • On a year-over-year basis, Selling, General & Administrative has increased for 26 consecutive quarters, with growth averaging 36.0% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 1.3% (Q1 2026) to 76.5% (Q4 2022).
  • Per Business Quant, the preceding three quarters came in at $33.07 million (Q1 2026), $32.22 million (Q4 2025) and $32.45 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 Vaxcyte 8.24 Bn 8.24 Bn - 34.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.93 Mn
Mar 31, 2026 33.07 Mn
Dec 31, 2025 32.22 Mn
Sep 30, 2025 32.45 Mn
Jun 30, 2025 32.04 Mn
Mar 31, 2025 32.66 Mn
Dec 31, 2024 28.56 Mn
Sep 30, 2024 22.99 Mn
Jun 30, 2024 21.47 Mn
Mar 31, 2024 19.89 Mn
Dec 31, 2023 17.53 Mn
Sep 30, 2023 15.61 Mn
Jun 30, 2023 14.46 Mn
Mar 31, 2023 13.11 Mn
Dec 31, 2022 11.95 Mn
Sep 30, 2022 10.90 Mn
Jun 30, 2022 9.42 Mn
Mar 31, 2022 7.54 Mn
Dec 31, 2021 6.77 Mn
Sep 30, 2021 6.52 Mn
API Access

Vaxcyte Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PCVX&period=max&api_key=YOUR_API_KEY